Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
PHASE1CompletedINTERVENTIONAL
Enrollment
44
Participants
Timeline
Start Date
June 18, 2007
Study Completion Date
April 15, 2009
Conditions
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus AOrthomyxovirdaeH5N1 Virus
Interventions
DRUG
VRC-AVIDNA036-00-VP
Trial Locations (1)
20892
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00489931 - Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally | Biotech Hunter | Biotech Hunter